Collegium Pharmaceutical Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Collegium Pharmaceutical Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Collegium Pharmaceutical Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Collegium Pharmaceutical Inc. is COLL:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Collegium Pharmaceutical Inc. has its primary listing on NASDAQ. You can trade Collegium Pharmaceutical Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Collegium Pharmaceutical Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Collegium Pharmaceutical Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Collegium Pharmaceutical Inc. or others.